Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease

Zeissig, S.; Bürgel, N.; Günzel, D.; Richter, J.; Mankertz, J.; Wahnschaffe, U.; Kroesen, A. J.; Zeitz, M.; Fromm, M.; Schulzke, J-D.
January 2007
Gut;Jan2007, Vol. 56 Issue 1, p61
Academic Journal
Background: Epithelial barrier function is impaired in Crohn's disease. Aim: To define the underIying cellular mechanisms with special attention to tight functions. Methods: Biopsy specimens From the sigmoid colon of patients with mild to moderately active or inactive Crohn's disease were studied in Ussing chambers, and barrier function was determined by impedance analysis and conductance scanning. Tight junction structure was analysed by freeze fracture electron microscopy, and tight junction proteins were investigated immunohistochemically by confocal laser scanning microscopy and quantified in immunoblots. Epithelial apoptosis was analysed in terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labelling and 4′ ,6-diamidino-2-phenylindole staining. Results: Patients with active Crohn's disease showed an impaired intestinal barrier function as indicated by a distinct reduction in epithelial resistance. As distribution of conductivity was even, focal epithelial lesions (eg, microerosions) did not contribute to barrier dysfunction. Instead, freeze fracture electron microscopy analysis showed reduced and discontinuous tight junction strands. Occludin and the sealing tight junction proteins claudin 5 and claudin 8 were downregulated and redistributed off the tight junction, whereas the pore- forming tight junctions protein claudin 2 was strongly upregulated, which constitute the molecular basis of tight junction changes. Other claudins were unchanged (claudins 1, 4 and 7) or not detectable in sigmoid colon (claudins 11, 12, 14, 15 and 16). Claudin 2 upregulation was less pronounced in active Crohn's disease compared with active ulcerative colitis and was inducible by tumour necrosis factor α. As a second source of impaired barrier function, epithelial apoptosis was distinctly increased in active Crohn's disease (mean (SD) 5.2 (0.5)% v 1 .9 (0.2)% in control). By contrast, barrier function, tight junction proteins and apoptosis were unaffected in Crohn's disease in remission. Conclusion: Upregulation of pore-forming claudin 2 and downregulation and redistribution of sealing claudins 5 and 8 lead to altered tight junction structure and pronounced barrier dysfunction already in mild to moderately active Crohn's disease.


Related Articles

  • Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor. Lippert, E.; Folk, W.; Bataille, F.; T. Kaehne; Naumann, M.; Goeke, M.; Herlarth, H.; Schoelmerich, J.; Rogler, G. // Gut;Jan2007, Vol. 56 Issue 1, p43 

    Background: Colonic lamina propria fibroblasts (CIPFs) play an important role in the pathogenesis of fibrosis and strictures in Crohn's disease. Aim: To identify colonic epithelial cell (CEC)-derived factors that activate CLPFs. Methods: Primary human CECs and CLPFs were isolated from control...

  • T cell apoptosis and inflammatory bowel disease. Peppelenbosch, M. P.; van Deventer, S. J. H. // Gut;Nov2004, Vol. 53 Issue 11, p1556 

    The article comments on the association of t-cell apoptosis and inflammatory bowel disease relative to the two studies published within the issue. The studies suggest that intrinsic defects in the control of programmed cell death in the mucosal t-cell compartment are associated in the...

  • IL-1 stimulates ceramide accumulation without inducing apoptosis in intestinal epithelial cells. Homaidan, Fadia R.; El-Sabban, Marwan E.; Chakroun, Iman; El-Sibai, Mirvat; Dbaibo, Ghassan S. // Mediators of Inflammation;Feb2002, Vol. 11 Issue 1, p39 

    Background: In inflammatory bowel disease (IBD), cytokine levels (such as interleukin-1 (IL-1)) are elevated. We have shown previously that IL-1 activates phospholipid signaling pathways in intestinal epithelial cells (IEC), leading to increased ceramide levels. Aim: To determine whether...

  • Structural Modification of the Gastrointestinal Epithelium during Immune-Dependent Granulomatosis. Nepomnyashchikh, D. L.; Burkovskaya, V. A.; Aidagulova, S. V.; Bakarev, M. A.; Postnikova, O. A.; Kapustina, V. I.; Nokhrina, Zh. V.; Vinogradova, E. V. // Bulletin of Experimental Biology & Medicine;Feb2011, Vol. 150 Issue 4, p490 

    We present results of pathomorphological study of the mucosa epithelium in various parts of the gastrointestinal tract in Crohn's disease. Particular attention was paid to structural transformation of epithelial cells. Barrier dysfunction of the gastrointestinal mucosa was shown to be one of the...

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis. Thomas, Saskia; Baumgart, Daniel // Inflammopharmacology;Feb2012, Vol. 20 Issue 1, p1 

    Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent...

  • REGIONAL ENTERITIS. Berger, Samuel S. // American Journal of Gastroenterology;Jul1956, Vol. 26 Issue 1, p81 

    Presents a case of a patient with regional enteritis. Persistence of abdominal pains suffered by the patient; Examination of the abdomen of the patient; Pathology of the regional enteritis.

  • Non Perianal Fistulas in Crohn's Disease and Short Bowel Syndrome: What We Can Do? Zildzic, Muharem; Alibegovic, Ervin // Medicinski Arhiv;2009, Vol. 63 Issue 6, p354 

    Crohn s disease (CD) is a lifelong disease arising from an interaction between genetic and environmental factors, but seen predominantly in the developed countries of the world. The precise etiology is unknown and therefore a causal treatment is not yet available. Fistulating Crohn's disease...

  • European evidence-based consensus on the diagnosis and management of Crohn's disease. Hanauer, S. B.; Sandborn, W. J. // Gut;Feb2007, Vol. 56 Issue 2, p161 

    The article discusses the evidence-based consensus on the management and diagnosis of Crohn's disease in Europe. A consensus was established by The European Crohn's and Colitis Organization (ECCO) on the promotion of views, clinical trials and specialist training in inflammatory bowel diseases....


Read the Article


Sign out of this library

Other Topics